Myriad Genetics (MYGN) Interest Expenses (2009 - 2026)

Myriad Genetics (MYGN) has reported Interest Expenses for 18 consecutive years, with $18.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Interest Expenses changed 0.0% year-over-year to $18.2 million; the TTM figure through Mar 2026 stood at $18.2 million (changed 0.0% YoY), while the FY2025 annual figure was $30.3 million, down 72.92% from the prior year.
• Interest Expenses grew to $18.2 million in Q1 2026 per MYGN's latest filing, from $2.3 million in the prior quarter.
• Across five years, Interest Expenses topped out at $79.6 million in Q1 2023 and bottomed at -$200000.0 in Q4 2024.
• Historically, Interest Expenses has averaged $20.4 million across 5 years, with a median of $5.8 million in 2025.
• Annual changes were most pronounced in 2023 — Interest Expenses jumped 8744.44% — and 2024, when it slumped 133.33%.
• Myriad Genetics' Interest Expenses stood at $77.8 million in 2022, then plunged by 99.23% to $600000.0 in 2023, then sank by 133.33% to -$200000.0 in 2024, then jumped by 1250.0% to $2.3 million in 2025, then soared by 691.3% to $18.2 million in 2026.
• Business Quant data shows MYGN's Interest Expenses at $18.2 million in Q1 2026, $2.3 million in Q4 2025, and $9.3 million in Q3 2025.